Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

INTERIM REPORT Q4 2019

Summary Financial overview October 1 – December 31, 2019 · Net sales amounted to SEK 0.0 M (0.0) · Loss for the period was SEK 244,9 M (loss: 112.0) · Loss per share, before and after dilution, was SEK 4.42 (loss: 2.54) · On December 31 cash and cash equivalents amounted to SEK 926.2 M (375.6) Significant events during the period October 1 – December 31, 2019 · In early December, an advisory meeting was held with the FDA is preparing for Oncopeptides’application for accelerated market approval · At the annual American Hematology Meeting (ASH) in December,

InDex Pharmaceuticals Holding AB (publ) year-end report 2019

Cobitolimod’s outstanding combination of efficacy and safety confirmed in in-depth analysis“The robustness and consistency of the CONDUCT results support our strategy to move cobitolimod forward in development and our phase III preparations are continuing according to plan,” says Peter Zerhouni, CEO of InDex Pharmaceuticals.    Period October – December 2019 · Net sales amounted to SEK 0.0 (0.0) million · Operating loss amounted to SEK –25.6 (–22.3) million · Result after tax amounted to SEK –25.6 (–22.3) million, corresponding to SEK –0.29 per share (–0.33) before and

Revenio Group Corporation: Financial Statement Bulletin, January 1 - December 31, 2019

Stock Exchange Release, February 20, 2020 at 9.00 amFinancial Statement Bulletin, January 1 - December 31, 2019 This release is a summary of Revenio Group’s January-December 2019 financial statement bulletin. The complete report is attached to this release as a pdf-file. The stock exchange release is also available on the company’s website at www.reveniogroup.fi/en Revenio ended the year with very strong growth driven by the successful CenterVue acquisition October–December 2019 · Net sales totaled EUR 14.9 (8.7) million, up 72.2% · Operating profit was EUR 5.2 (3.0)

INTERNATIONELLA ENGELSKA SKOLAN INTERIM REPORT 1 JULY-31 DECEMBER 2019/2020

Second quarter (October-December) · Operating income increased 12.1% to MSEK 813.5 (725.7), of which organic growth amounted to 9.9% · The number of students in the Swedish schools at the end of the quarter was 26,814 (25,608) · The number of registrations in the queue in Sweden at the end of the quarter was approx. 208,900 (188,000) · EBIT amounted to MSEK 86.2 (50.3). Excl. the effects of the introduction of IFRS 16, EBIT amounted to MSEK 68.1 (50.3) · The EBIT margin was 10.6% (6.9). Excl. IFRS 16, the EBIT margin was 8.4% (6.9) · Profit for the quarter totalled MSEK

Update to Konecranes Plc’s Nomination Board's proposal for the composition of the Board of Directors

KONECRANES PLC STOCK EXCHANGE RELEASE February 20, 2020 at 09.00 EETUpdate to Konecranes Plc’s Nomination Board's proposal for the composition of the Board of DirectorsAfter the proposal published on January 31, 2020 by Konecranes Plc’s shareholders' Nomination Board to the Annual General Meeting, Mr. Anders Nielsen, a current member of the Board of Directors, has informed the Nomination Board that due to changed personal circumstances he will have to withdraw his availability for re-election to the Konecranes Board in the Annual General Meeting.As a result of this change, the

Year-End Report 2019 Everysport Media Group AB (publ.)

Consumer revenue boosts earningsThis is a translated version of the Swedish original, in case of deviations is the Swedish version considered to be the one to apply. This information is such information that Everysport Media Group AB (publ.) Is required to publish in accordance with the EU Market Abuse Regulation. The information was provided, through the agency of the above contact person, for publication on February 20th, 2020 Summary of the fourth quarter 2019: • Net sales: 22,6 mkr (23,7 mkr)• EBITDA: 2,8 mkr (2,6 mkr)• Profit after tax: -1,7 mkr (-1,1 mkr) • Earnings per

myFC Holding AB (publ) year-end report January – December 2019

Full year January – December 2019· Net sales amounted to KSEK 0 (577) · Operating loss amounted to SEK -165 million (-91). · Earnings per share amounted to SEK -1.76 (-1,63) Quarter October – December 2019 · Net sales amounted to KSEK 0 (110) · Operating loss amounted to SEK -17 million (-35). · Earnings per share amounted to SEK -0.15 (-0,51) Significant events October – December · The Board of Directors of myFC proposes a targeted new share issue · Helvetican International nominates two members to the Board of myFC · myFC executes decisions on directed

ContextVision Sees Strong Momentum in 2019 Across Medical Imaging and Digital Pathology Sectors

STOCKHOLM – February 20, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced solid sales in Q4 to close out a record year for the company. With sales growth across its medical imaging offerings and patent approval for its unique method for high-quality digital pathology data generation, this past quarter has set a strong foundation for the future of the company. Sales in the fourth quarter ended at 28.1 MSEK, a small increase compared to the fourth quarter in 2018. Sales in 2019 ended at 95.3 MSEK.

Volati presents new financial targets

Volati’s Board has adopted new financial targets and an updated dividend policy, which replace the previous financial targets communicated in connection with the IPO in 2016. The strategic direction stands firm, but with the new targets, the Company wants to consolidate its strong long-term focus on value growth.  Volati’s overall objective remains to generate long-term value growth by building an industrial group of profitable companies with solid cash flows and capacity for continuous development. “Since Volati’s ordinary shares were listed on Nasdaq Stockholm in 2016, the Company’s

Year-end report January–December 2019

Q4 October–December 2019 · Net sales amounted to SEK 1,801 (1,831) million · EBITDA increased to SEK 291 (210) million · EBITA increased by 12 percent to SEK 194 (173) million · Organic EBITA growth was 3 percent · Profit after tax increased by 35 percent to SEK 163 (121) million · Earnings per ordinary share increased by 40 percent to SEK 1.82 (1.30) Period January–December 2019 · Net sales increased by 12 percent to SEK 6,833 (6,084) million · EBITDA increased to SEK 909 (552) million · EBITA increased by 18 percent to SEK 513 (433) million · Organic

Recipharm AB publishes report for the fourth quarter and full year 2019

October – December 2019 · Net sales amounted to SEK 1,981 million (1,739), an increase of 14% · EBITDA increased by 31% and amounted to SEK 367 million (280) corresponding to an EBITDA margin of 18.5% (16.1) · Operating profit (EBIT) amounted to SEK 117 million (-2) and was negatively affected by non-recurring items of SEK -52 million (-129) · Profit after tax amounted to SEK 90 million (-41) corresponding to a net margin of 4.5% (-2.3) · Earnings per share amounted to SEK 1.32 (-0.59) before dilution and SEK 1.32 (-0.59) after dilution. Adjusted for non-recurring items

Redeye: G5 Entertainment - Broadening its Portfolio

Redeye leaves its valuation range and estimates roughly unchanged following broadly in-line 4Q’19 results. We expect the monetization metrics of rising star “Jewels of Rome” to be in good shape due to high monthly growth in the game following major User Acquisition investments, whereas the company confirms that pipeline investments may continue to compromise margins in 2020. Read more and download the research update by Tomas Otterbeck: http://bit.ly/2P6HzKAStart following G5 Entertainment  at Redeye to instantly receive our latest equity

Strong cash flow, good order intake and increased dividend

The fourth quarter: October – December · Net sales increased 10 percent to 333 MSEK (304) · Order intake increased 15 percent to 352 MSEK (305) · Order backlog increased 26 percent to 1,522 MSEK (1,204) · Operating profit increased 40 percent to 38 MSEK (27) · Net profit after tax increased 37 percent to 26 MSEK (19) · Earnings per share increased to 1.11 SEK before dilution and 1.10 SEK after dilution (0.86) · Operating cash flow increased to 100 MSEK (28) The full year 2019: January – December · Net sales increased 15 percent to 1,221 MSEK (1,058) · Order

Interim report May-January 2019/20

Outlook maintained for the full-year – soft quarter We delivered an improved EBITA margin supported by good sales in Neuro and Oncology Informatics as well as by our cost reduction program. However, the third quarter was disappointing from an order perspective as the U.S. business did not live up to our expectations. Our order pipeline of Elekta Unity is strong, which ensures that the order target will be met – most likely already in the fourth quarter.  Richard HausmannPresident and CEO Third quarter · Gross order intake amounted to SEK 4,276 M (4,551), corresponding to an

Year-End Report January - December 2019

Growing aftermarket and contracting services drive earningsFOURTH QUARTER 2019 · Revenue decreased 6% (15% decrease in local currency) to SEK 960m (SEK 1,019m) · Operating profit increased 13% to SEK 95m (SEK 84m) · Operating margin was 9.9% (8.3%) · The result for the period decreased 10% to SEK 57m (SEK 64m) · Earnings per ordinary share amounted to SEK 3.95 (SEK 4.40) · Cash flows from operating activities amounted to SEK 3m (SEK 12m)  JANUARY-DECEMBER 2019 · Revenue increased 16% (9% increase in local currency) to SEK 3,747m (SEK 3,241m) · Operating profit

Notice to the Annual General Meeting of Nordea Bank Abp

Nordea Bank Abp – Stock exchange release – Notice to general meeting The shareholders of Nordea Bank Abp (the “Company”) are hereby summoned to the Annual General Meeting to be held on Wednesday 25 March 2020 at 1.00 pm EET at Messukeskus Helsinki, Expo and Convention Centre, Messuaukio 1, 00520 Helsinki. The reception of persons who have registered for the meeting will commence at 11.00 am EET. A.      Matters on the agenda of the Annual General Meeting At the Annual General Meeting, the following matters will be considered: 1.         Opening of the meeting 2.

Foundation for growth with a balanced risk-taking

Summary October – December 2019 · Net sales for projects run entirely by SSM increased to 36.1 MSEK (58.2). · Net operating profit was 1.0 MSEK (-33.6).  · 165 tenants moved into the West Side Solna co-op project. The result will be delayed somewhat since the project is being run as a JV, result for the quarter was impacted by 23.1 MSEK. Tenants will continue moving in during 2020. · Cash flow from operating activities totaled 33.5 MSEK (-2.8). Sale of Bromma Boardwalk project to Niam had a 27.1 MSEK impact on cash flow.  · Land allocation for 150 co-op units in

Notice to attend the Annual General Meeting of Skanska AB (publ)

The shareholders of Skanska AB (publ), reg. no. 556000–4615 (the “Company”), are hereby invited to participate in the Annual General Meeting (the “Meeting”) to be held on Thursday March 26, 2020 at 10.00 a.m. CET at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4, Stockholm, Sweden. Registration will begin at 9.00 a.m. CET. Coffee and sandwich will be served before the Meeting.Right to participate Shareholders who wish to participate in the Meeting must · be recorded in the share register kept by Euroclear Sweden AB on Friday March 20, 2020; and · give notice of intent

Pricer Receives Additional Follow-up Order from Leading US Retailer

Best Buy has placed an additional order to complete the US deployment of Pricer’s Electronic Shelf Labels (ESL) system in approximately 230 stores. The estimated value of the new order is SEK 300 million and will be included in Pricer’s order intake for the first quarter of 2020. Deliveries under this order are planned to begin in the second quarter of 2020 and to be completed before the end of 2020.  For further information, please contact:Donald Charles Jackson, President Pricer, Inc., +1 404 863-2399Helena Holmgren, President & CEO Pricer AB, +46 (0)702 870 068Susanne

Year-end report 2019

A year of strong growth in sales and earnings.A quarter with good growth, but lower margin.Fourth quarter[1] · Consolidated net sales increased by 18.9 per cent to SEK 93.5 million (78.7). · Operating profit (EBIT) decreased by SEK 0.7 million to SEK 1.5 million (2.2). · Earnings per share after dilution amounted to SEK 0.01 (0.02). Full-year 2019, January – December 2019[1] · Consolidated net sales increased by 37.2 per cent to SEK 370.6 million (270.1). · Operating profit (EBIT) increased by SEK 30.5 million to SEK 32.0 million (1.5). · Earnings per share after

Sinch AB (publ): Year-end report January – December 2019

Year-end report January – December 2019 October – December 2019 • Net sales increased by 34 percent to SEK 1,540.7 million (1,151.3). Organic growth in local currency was 17 percent.• Gross profit increased by 42 percent to SEK 439.9 million (309.9). Organic growth in local currency was 23 percent.• Adjusted EBITDA[1] increased by 82 percent to SEK 199.5 million (109.4).• Adjusted EBIT[2] amounted to SEK 185.7 million (104.1).• Profit after tax for the quarter amounted to SEK 94.7 million (103.5).• Diluted earnings per share were SEK 1.73 (1.93). January – December 2019

SSM appoints Ola Persson as CFO

SSM has appointed Ola Persson as the company’s new Chief Financial Officer. Ola has been working at SSM since 2013 and is currently Finance Manager and member of SSM’s Executive Management Team. - With his extensive experience at SSM, Ola has in-depth knowledge about the company’s projects, joint ventures and financial solutions. I look forward to work with Ola in his new position within the Group, says Mattias Lundgren, President & CEO of SSM. Ola Persson will start his role as CFO on March 1, 2020.   This information is information that SSM Holding AB (publ) is obliged to make

TOMRA: Key information relating to the proposed cash dividend to be paid

Dividend amount: Ordinary dividend of NOK 2.75 per share Declared currency: NOK Last day including right: 4 May 2020 Ex-date: 5 May 2020 Record date: 6 May 2020 Payment date: On or about 18 May 2020 Date of approval: 4 May 2020 *** This information is published in accordance with the requirements of the Continuing Obligations. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

There are no items matching the current filter
There are no more items matching the current filter
Back to top